Clinical Trial Update: Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough [NA]

View source ↗

Summary

Clinical trial update on using fractional exhaled nitric oxide to guide Montelukast treatment for subacute cough; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subacute Cough

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Coughing | NA | Status: UNKNOWN